OpGen, Inc. (OPGN) News Headlines

▮ More

Date

Headline

4/5/2022 7:39:21 AM OpGen Announces Interim Analysis Results From Clinical Trial For Unyvero Urinary Tract Infection Panel

10/4/2021 8:57:23 AM OpGen Gets FDA Clearance To Market Acuitas AMR Gene Panel - Quick Facts

10/4/2021 5:21:20 AM Pre-market Movers: AMPY, OPGN, FAMI, ADVM, PED…

9/9/2021 5:34:38 AM Pre-market Movers: HGEN, PMCB, CRDF, HLBZ, LULU…

9/8/2021 5:52:00 AM Pre-market Movers: JAGX, KDMN, ARQQ, IGC, NCMI, MTL…

6/7/2021 7:38:53 AM OpGen Submits Updated 510(k) Summary To FDA For Acuitas AMR Gene Panel For Isolates

1/13/2021 7:35:02 AM OpGen Q4 Revenue $1.3 Mln Vs $0.8 Mln Last Year

Older Articles

Opgen, Inc. (OPGN)